Today is the 1st of November.
The 1st of November is the start of Pancreatic Cancer awareness month.
This is my 12th Pancreatic Cancer awareness month since my adorable Seth died in June 2014.
Over the last 12 years, I have done many things to raise awareness during the annual 30 days of November which is included Fundraising quizzes balls wearing purple clothes, hats and jewelry selling purple pottery and being active on social media.
Much of the activity over the last 12 years has been focused on raising awareness awareness of a disease that affects 10 1/2 thousand people per year and of those people in the UK the majority do not survive.
Little has changed over the last 50 years survival rates of remained stubbornly consistent for every 10 people diagnosed with Pancreatic Cancer in the UK. One gets the chance of life-saving surgery to get chemo and the remaining seven sadly still get no active treatment whatsoever 50% of the people diagnosed die within three months and after all these years type in these figures still cause me causes me to take a Shop intake of breath.
This Pancreatic Cancer awareness month things feel slightly different although the figures remain stubbornly consistent and although the statistics quoted are still true, there is a change.
Due to the focus and dedication of many scientist researchers clinicians and patients and carers across the world it feels like Pancreatic Cancer is on the cost of a breakthrough.
The development of the new drug racks on Rasi which has been researched in the US and has for people with incurable Pancreatic Cancer increased the survival rate from 6.2 months average to 13.7 that is a huge huge step forward a step forward the Will help people with Pancreatic Cancer that is incurable live longer the drug has found away of working with a protein called Cara and this is the first step to maybe making Pancreatic Cancer Cancer that will respond to drugs in the future whereas previously it should been termed on drug Abel.
This new drug has also now been authorised in the EU and hopefully soon it will go through regulatory processes and become available subject to those processes in the UK.
There are also many research projects looking at things like using Peapell‘s breath to test for earlier diagnosis of Pancreatic Cancer. There are biomarker work going on to use blood and urine to detect Pancreatic Cancer and lots of work going on with MNRA vaccines that will hopefully soon rape the years of research into improved outcomes for people diagnosed with the disease.
So although the picture hasn’t really changed, it has on the future for Pancreatic Cancer is looking as bright as it has for any of the years in the 12th since Seth died so the focus of Pancreatic Cancer awareness month for me this year is to share some of those developments research projects activities and share the hope with others as well as continuing to raise awareness of the signs and symptoms which is brutally important given the current survival rates.
All of this will be done in memory of my adorable Seth and as part of Seth‘s Legacy, which has been built up over the last 12 years
Today is the 1st of November.
The 1st of November is the start of Pancreatic Cancer awareness month.
This is my 12th Pancreatic Cancer awareness month since my adorable Seth died in June 2014.
Over the last 12 years, I have done many things to raise awareness during the annual 30 days of November which is included Fundraising quizzes balls wearing purple clothes, hats and jewelry selling purple pottery and being active on social media.
Much of the activity over the last 12 years has been focused on raising awareness awareness of a disease that affects 10 1/2 thousand people per year and of those people in the UK the majority do not survive.
Little has changed over the last 50 years survival rates of remained stubbornly consistent for every 10 people diagnosed with Pancreatic Cancer in the UK. One gets the chance of life-saving surgery to get chemo and the remaining seven sadly still get no active treatment whatsoever 50% of the people diagnosed die within three months and after all these years type in these figures still cause me causes me to take a Shop intake of breath.
This Pancreatic Cancer awareness month things feel slightly different although the figures remain stubbornly consistent and although the statistics quoted are still true, there is a change.
Due to the focus and dedication of many scientist researchers clinicians and patients and carers across the world it feels like Pancreatic Cancer is on the cost of a breakthrough.
The development of the new drug racks on Rasi which has been researched in the US and has for people with incurable Pancreatic Cancer increased the survival rate from 6.2 months average to 13.7 that is a huge huge step forward a step forward the Will help people with Pancreatic Cancer that is incurable live longer the drug has found away of working with a protein called Cara and this is the first step to maybe making Pancreatic Cancer Cancer that will respond to drugs in the future whereas previously it should been termed on drug Abel.
This new drug has also now been authorised in the EU and hopefully soon it will go through regulatory processes and become available subject to those processes in the UK.
There are also many research projects looking at things like using Peapell‘s breath to test for earlier diagnosis of Pancreatic Cancer. There are biomarker work going on to use blood and urine to detect Pancreatic Cancer and lots of work going on with MNRA vaccines that will hopefully soon rape the years of research into improved outcomes for people diagnosed with the disease.
So although the picture hasn’t really changed, it has on the future for Pancreatic Cancer is looking as bright as it has for any of the years in the 12th since Seth died so the focus of Pancreatic Cancer awareness month for me this year is to share some of those developments research projects activities and share the hope with others as well as continuing to raise awareness of the signs and symptoms which is brutally important given the current survival rates.
All of this will be done in memory of my adorable Seth and as part of Seth‘s Legacy, which has been built up over the last 12 years
Today is 1 November.
It marks the start of Pancreatic Cancer Awareness Month.
This is my 12th Pancreatic Cancer Awareness Month since my adorable Seth died, just 33 short and heart-breaking days after his pancreatic cancer diagnosis in June 2014.
Over the last 12 years, I have done many things to raise awareness throughout November: fundraising, quizzes, balls, standing in supermarkets, wearing purple clothes, hats and jewellery, selling purple pottery, and being active on social media.
Much of this activity has focused on raising awareness of a disease that affects 10,500 people each year in the UK, the majority of whom do not survive.
Little has changed over the last 50 years: survival rates have remained stubbornly stalled.
For every 10 people diagnosed with pancreatic cancer in the UK, one gets the chance of life-saving surgery, two receive chemotherapy, and the remaining seven sadly still receive no active treatment whatsoever.
50% of those diagnosed die within three months. Even after all these years, typing these figures still makes me draw a sharp breath in disbelief.
But this Pancreatic Cancer Awareness Month, in 2026, feels slightly different. Although the figures remain the same and the statistics quoted are still true, there is a sense of change.
Thanks to the focus and dedication of scientists, researchers, clinicians, patients and carers across the world, it feels as though pancreatic cancer is on the cusp of a breakthrough. Daraxonrasib (brand name Rasonque) is an oral RAS‑inhibiting anticancer drug approved in 2026 in the EU and US for adults with metastatic pancreatic adenocarcinoma, particularly after at least one prior systemic therapy. Average survival for people with metastatic pancreatic cancer has increased from 6.2 months to 13.7 months.
That is a huge, huge step forward — one that will help people with pancreatic cancer.
With this new drug now authorised in the EU and US, I hope it will soon progress through the UK’s regulatory processes and, subject to approval, become available here too.
There are also research projects exploring breath tests to identify pancreatic cancer earlier, and biomarkers in blood and urine to help detect the disease. Work on mRNA vaccines also offers hope that years of research will soon translate into improved outcomes for people diagnosed with pancreatic cancer.
So, although the experience of people diagnosed with pancreatic cancer has been slow to change, the future looks brighter than at any point in the 12 years since Seth died.
My focus this Pancreatic Cancer Awareness Month is to share some of these new developments and research projects.
I want to share that hope with others while continuing to raise awareness of the signs and symptoms — something that remains vitally important given the current survival rates.
All of this will be done in memory of my adorable Seth, and as part of Seth’s Legacy, which has been built over the last 12 years.
